Genome-wide DNA methylation analysis in hepatocellular carcinoma

Nobuhisa Yamada(Kyoto Prefectural University of Medicine), Yoshito Itoh(Fukui-ken Saiseikai Hospital), Yasuyuki Gen(Kyoto Prefectural University of Medicine), Taichiro Nishikawa(Kyoto Prefectural University of Medicine), Atsushi Umemura(University of California San Diego), N. Iwai(Kyoto Prefectural University of Medicine), Yoshio Sumida(Kyoto Prefectural University of Medicine), Shinji Tanaka(Tokyo Institute of Technology), Yuji Naito(Kyoto Prefectural University of Medicine), Akira Tomie(Kyoto Prefectural University of Medicine), Osamu Dohi(Kyoto Prefectural University of Medicine), Kanji Yamaguchi(Kyoto Prefectural University of Medicine), Tomoko Kitaichi(Kyoto Prefectural University of Medicine), Kohichiroh Yasui(Kyoto Prefectural University of Medicine), Hironori Mitsuyoshi(Kyoto Prefectural University of Medicine), Shigeki Arii(Kyoto University), Michihisa Moriguchi(Kyoto Prefectural University of Medicine)
Oncology Reports
February 11, 2016
10.3892/or.2016.4619
Cited by 79

Related Papers

NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria
|Cell|2016|1.1k
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
|Hepatology|2007|1k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277